Jason E. Faris

Vemurafenib in Multiple Nonmelanoma Cancers with <i>BRAF</i> V600 Mutations

David M. Hyman, Igor Puzanov, Vivek Subbiah et al. · New England Journal of Medicine · 2015 · 1.7K citations · Full text

Medicine, Oncology, Pharmacology +12

Radiological and Surgical Implications of Neoadjuvant Treatment With FOLFIRINOX for Locally Advanced and Borderline Resectable Pancreatic Cancer

Cristina R. Ferrone, Giovanni Marchegiani, Theodore S. Hong et al. · Annals of Surgery · 2014 · 837 citations · Full text

Medicine, Oncology, Surgery +17

Total Neoadjuvant Therapy With FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma

Janet E. Murphy, Jennifer Y. Wo, David P. Ryan et al. · JAMA Oncology · 2018 · 543 citations · Full text

Medicine, Oncology, Surgery +17

Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers

Aparna R. Parikh, Ignaty Leshchiner, Liudmila Elagina et al. · Nature Medicine · 2019 · 522 citations

Medicine, Oncology, Pathology +16

Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer

Janet E. Murphy, Jennifer Y. Wo, David P. Ryan et al. · JAMA Oncology · 2019 · 510 citations · Full text

Medicine, Oncology, Surgery +17